We're so glad you're here the resilient cycle method
The Resilient Cycle Method™
Functional Nutrition + GLP-1 Coaching for Women
Book an Appointment
Inside the program we focus on:
✔ Preparing the liver and drainage pathways BEFORE starting medication using The Core Four Method (6-week foundational reset)
✔ Managing low appetite so nutrient intake stays adequate
✔ Reversing insulin resistance with the Happy Hormones Method, the style of eating that helps us keep a balanced relationship with food, while keeping carbs and sugars moderately low
✔ Tracking strength, fitness and body composition and supporting you in adjusting GLP-1 dosing with all this in mind
✔ Supporting ovulation with key nutrients and minerals
✔ Nervous system regulation through accountability, support and connection
Program tools
Supplement and Functional Food Library
Unfiltered Nourishment App
View your workout program
Track meals for us to review
Ask questions and share wins in the group message
Monthly check in forms
Complete your monthly check in which you’ll receive by email at the beginning of each month
recent studies on GLP-1s and women’s health
1. Meta-Analysis: GLP-1 RAs Improve Weight, Insulin Resistance & Hormones in PCOS
A 2025 meta-analysis of randomized clinical trials found that GLP-1 receptor agonists in women with PCOS significantly:
Reduced body weight, BMI, waist circumference and waist-to-hip ratio
Improved glucose homeostasis (fasting insulin, OGTT outcomes, HOMA-IR)
Showed mixed effects on lipid profiles
These agents were compared to placebo or metformin and demonstrated benefits on metabolic parameters central to PCOS pathophysiology.
👉 Key takeaway: GLP-1RAs can improve metabolic dysfunction, a core driver of PCOS symptoms.
References:
Lin S, Deng Y, Huang J, Li M, Sooranna SR, Qin M, Tan B. Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials. Sci Rep. 2025 May 13;15(1):16512. doi: 10.1038/s41598-025-99622-4. PMID: 40360648
2. GLP-1 Combination Reduced Endometrial Cancer Risk by 66%
When combined with progestin, GLP-1s reduced risk of endmetrial cancer by 66% in a study done with 444,820 patients. Those who also used Metformin had even greater reductions in risk.
👉 Key takeaway: GLP-1s don’t just reduce appetite, they lower inflammation which is a driving force in chronic diseases. Blood sugar and sex hormone management is also a key factor in women’s health.
References:
Yen T, Yi Jin Hsieh T, Lee G, et al. GLP-1 receptor agonists plus progestins and endometrial cancer risk in nonmalignant uterine diseases. JAMA Netw Open. February 10, 2026. doi:10.1001/jamanetworkopen.2025.58205
Upcoming events
TBD
Hormone Resiliency Habits
TBD
Nutrition Review Sessions
TBD
Yoga & Meditation for All Bodies